Elevance Health stock touches 52-week low at $397.93
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Elevance Health Inc (ELV)Elevance Health Inc stock price live, this page displays NYSE ELV stock exchange data. View the ELV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Elevance Health Inc real time stock price chart below.
What Is the Elevance Health Inc Stock Price Today?
The Elevance Health Inc stock price today is 408.07.
What Is the Stock Symbol for Elevance Health Inc?
The stock symbol for Elevance Health Inc is ""ELV.""
What Stock Exchange Does Elevance Health Inc Trade On?
Elevance Health Inc is listed and trades on the NYSE stock exchange.
Is Elevance Health Inc a Good Stock to Buy?
Determining whether Elevance Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELV quote. (ISIN: US0367521038)
What Is the Elevance Health Inc Stock Price Today?
The Elevance Health Inc stock price today is 408.07.
What Is the Stock Symbol for Elevance Health Inc?
The stock symbol for Elevance Health Inc is ""ELV.""
What Stock Exchange Does Elevance Health Inc Trade On?
Elevance Health Inc is listed and trades on the NYSE stock exchange.
Is Elevance Health Inc a Good Stock to Buy?
Determining whether Elevance Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELV quote. (ISIN: US0367521038)
408.07
-2.32(-0.57%)
Closed
After Hours
409.15+1.08(+0.26%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
406.78
412.34
52 wk Range
391.02
567.26
ELV Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
406.78412.34
52 wk Range
391.02567.26
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(1.60%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(1.60%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockELV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
520.12
Upside
+27.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Wellpoint Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Elevance Health stock touches 52-week low at $397.93
- Investing.com
- Wellpoint Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Elevance Health Inc Company Profile
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Elevance Health Inc SWOT Analysis
Resilient Amid Headwinds | Elevance Health navigates Medicaid challenges while maintaining strong market position and growth potential in specialty sales and other segments |
Strategic Expansion | Delve into Elevance's recent acquisitions in specialty pharmacy, positioning the company for significant growth and vertical integration |
Financial Outlook | Analysts project EPS of $37.31 for the current fiscal year, with an average price target of $599, indicating confidence in future performance |
Industry Dynamics | Explore how Elevance adapts to healthcare trends, including Medicaid redetermination and Medicare cost management, shaping its competitive edge |
ELV Full Pro Research
Institutional-Grade Stock Analysis
Understand how ELV earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Elevance Health Inc Earnings Call Summary for Q4/2024
- Q3 adjusted EPS at $8.37, below expectations; full-year outlook revised to $33 due to Medicaid challenges
- Commercial membership grew by 600,000 YoY; total operating revenue up 5% to $44.7 billion
- Consolidated benefit expense ratio rose to 89.5%; Medicaid costs 3x-5x historical averages
- Projecting high single-digit revenue growth and mid-single-digit EPS growth for 2025
- Anticipating Medicare Advantage growth and Medicaid margin improvements in 2025
Last Updated: 18/10/2024, 12:04
Read Full TranscriptCompare ELV to Peers and Sector
Metrics to compare | ELV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipELVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.7x | 11.3x | −0.7x | |
PEG Ratio | 1.62 | 0.07 | 0.00 | |
Price/Book | 2.2x | 1.7x | 2.6x | |
Price / LTM Sales | 0.5x | 0.8x | 3.2x | |
Upside (Analyst Target) | 26.7% | 11.6% | 46.4% | |
Fair Value Upside | Unlock | −1.8% | 6.9% | Unlock |
Analysts' Recommendations
19 Buy
3 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 520.12
(+27.46% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 27.57
Dividend Yield
1.59%
Industry Median 1.30%
Annualised payout
6.5200
Paid quarterly
5-Years Growth
+15.12%
Growth Streak
People Also Watch
FAQ
What Is the Elevance Health (ELV) Premarket Price Today?
The Elevance Health (ELV) premarket price is . Premarket price change units: . Premarket percentage change: . Premarket volume: . Current date: 04 Dec 2024. Previous close: 410.39
What Stock Exchange Does Elevance Health Trade On?
Elevance Health is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Elevance Health?
The stock symbol for Elevance Health is "ELV."
What Is the Elevance Health (ELV) Afterhours Price Today? (Afterhours variable test: ) Current Date: 04 Dec 2024
After hours price: . After hours price change (units): . Price change percentage:
What Is the Elevance Health Market Cap?
As of today, Elevance Health market cap is 94.64B.
What is Elevance Health Earnings Per Share?
The Elevance Health EPS is 27.57.
What Is the Next Elevance Health Earnings Date?
Elevance Health will release its next earnings report on 21 Jan 2025.
From a Technical Analysis Perspective, Is ELV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Is Elevance Health (ELV) Price Target According to Analysts?
Based on analysts, the average 12-month price target for Elevance Health is , with a high estimate of and a low estimate of . analysts recommend buying the stock, while suggest selling, leading to an overall rating of . The stock has an upside potential of %.
What Is Elevance Health (ELV) Price Target According to Analysts?
Based on analysts, the average 12-month price target for Elevance Health is , with a high estimate of and a low estimate of . analysts recommend buying the stock, while suggest selling, leading to an overall rating of . The stock has an upside potential of %.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.